NCT05299099View on ClinicalTrials.gov

Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Inj. Compared With RCN301

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 4, 2022

Primary Completion Date

December 9, 2022

Study Completion Date

December 15, 2022

Conditions
Parenteral Nutrition
Interventions
DRUG

IN-C006 inj.

IN-C006 will be injected continuously for 3 days.

DRUG

RCN301

RCN301 will be injected continuously for 3 days.

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY

NCT05299099 - Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Inj. Compared With RCN301 | Biotech Hunter | Biotech Hunter